CAMBRIDGE, MA / ACCESS Newswire / August 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal ...

BioNTech SE BNTX +3.21% Get Free Report reported a second-quarter per-share loss of $1.82 (1.60 euros) on Monday, up from a loss of 3.36 euros reported a year ago, compared to beating the consensus ...

EU Commission deleted important text messages between von der Leyen and Pfizer CEO Bourla from vaccine negotiations. Chief of ...

The company expects that the U.S. COVID-19 vaccination rate will be “maybe a couple of points lower” than the prior level of ...

BioNTech’s second-quarter earnings came in at a loss of 1.60 euros a share on revenue of €261 million ($302.1 million), ...

Berkshire Hathaway (NYSE: BRKa) stock fell 0.6% after Warren Buffett’s sprawling conglomerate posted a $3.76 billion ...

BioNTech (BNTX) stock gains as the company surpasses Q2 2025 forecasts with 103% YoY revenue growth, thanks mainly to Pfizer ...

Continued execution of BioNTech’s oncology strategy with focus on two pan-tumor programs including two announced transactions: mRNA-based cancer immunotherapy candidates and BNT327, a bispecific ...

German biotech firm BioNTech on Monday said that second-quarter revenues more than doubled to 261 million euros ($302 million ...

Summer heat, outdoor fun … and cold and flu symptoms? The three may not go together in many people’s minds: partly owing to ...

We’ll see another busy week for earnings , with reports also coming from BioNTech, GlobalFoundries, Rivia, Occidental, and ...